key: cord-0913402-l51jvqx4
authors: Bunel, Vincent; Saker, Loukbi; Ajzenberg, Nadine; Timsit, Jean Francois; Najem, Samer; Lortat-Jacob, Brice; Gay, Juliette; Weisenburger, Gaelle; Mal, Hervé; Khalil, Antoine
title: Pulmonary embolism detected by CT pulmonary angiography in hospitalized COVID-19 patients
date: 2021-04-08
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2021.03.007
sha: 5615882cc374179bb2f0ed5bf95f85107aa4e806
doc_id: 913402
cord_uid: l51jvqx4

nan

Besides pneumonia, the most frequent serious manifestation of COVID-19, another prominent manifestation is venous thromboembolism (VTE) (1) . Data on the prevalence/incidence of pulmonary embolism (PE) in COVID-19 are still limited and often focused on patients in intensive care units (ICU) (2) (3) (4) . Moreover, few data are available on the severity of PE and on the severity of parenchymal involvement in those who develop PE.

Here, we present our data in 157 consecutive COVID-19 patients, hospitalized at Bichat Hospital, who underwent CT pulmonary angiography (CTPA) for suspected PE. For patients hospitalized for COVID-19, the general policy at our institution is to recommend use of anticoagulant therapy based on low-molecular-weight heparin or unfractionated heparin, the intensity varying from low-prophylactic doses to curative treatment via highprophylactic doses according to the severity of the respiratory condition, the presence of obesity or other risks factors of VTE. In all cases, CTPA was performed to exclude the responsibility of superimposed PE in patients hospitalized for severe COVID-19 and presenting stagnation or worsening of their respiratory condition. CT-angiography scans were acquired with 64-row or greater scanners after injection of 70-90 mL of contrast material with a high concentration of iodine. Imaging was performed with use of a bolus- Clinical and biological data are in the Table 1 .

D-dimers levels were significantly higher in ward patients with PE than those without; there was no difference in ICU patients. Using the age-adjusted D-dimers cut-off levels, the sensitivity, specificity, negative predictive value, and positive predictive value of D-Dimers for the diagnosis of PE was 100%, 26%, 100%, and 21% respectively ( Table 2 ).The ROC curve for D-dimer in hospitalized COVID patients with suspected PE is shown in Figure 1 . There is mounting evidence that COVID-19 patients, particularly critically ill patients, are at increased risk of VTE (2-4, 6, 7). The underlying mechanism involves factors related to COVID-19, such as inflammatory state, hypercoagulability, and endothelial damage, along with classical risk factors of VTE (older age, obesity, dehydration, immobilization, mechanical ventilation) which are often present with severe COVID-19.

A high incidence of PE in COVID-19 patients hospitalized in ICUs has been already reported (3, 4, 6, 7) but data in non-ICU patients remain limited (6) (7) (8) (9) . Our data confirm the high incidence of PE in COVID-19 patients hospitalized in ICU but also indicate that PE is also frequently observed in COVID-19 patients hospitalized in the general ward, justifying a high degree of awareness by clinicians.

Not surprisingly, we found that COVID-19 is associated with an hyperinflammatory state that contributes to the hypercogulability and in turn to the risk of VTE but the levels of CRP and fibrinogen did not differ between those with and without PE. Overall, D-Dimers levels were significantly higher in those with PE than in those without PE, in line with the results of other COVID-19 studies (2, 6, (8) (9) (10) . However, D-dimers were not able to predict thrombotic events, especially in ICU patients.

COVID-19 patients hospitalized in general wards because of severe illness are at risk of worsened condition leading, in the most severe cases, to admission to an ICU because of critical symptoms (respiratory failure, shock, multiple organ dysfunction). Likewise, in the J o u r n a l P r e -p r o o f ICU, physicians caring for COVID-19 patients are used to facing a general deterioration, with respiratory symptoms at the forefront. In both cases, progression of pneumonia is most often responsible for the observed worsening of the respiratory condition but the latter could also be related to the occurrence of PE or to PE superimposed on extending pneumonia. Age-adjusted D-dimers cut-off level (ng/ml) was age multiplied by 10. D-dimers were considered positive if they were above this threshold.

Abbreviations : PE : pulmonary embolism J o u r n a l P r e -p r o o f

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

Admission chest CT score predicts 5-day outcome in patients with COVID-19

Incidence of venous thromboembolism in hospitalized patients with COVID-19

Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors

Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome

The combined use of end-tidal carbon dioxide and alveolar dead space fraction values in the diagnosis of pulmonary embolism

Data are presented as median [interquartile range] or number (percentage) where appropriate. Groups with and without PE were compared by Mann-Whitney U test or chi-square test, for quantitative and categorical variables

Biological data from samples obtained within 48 hr before or after CT pulmonary angiography in the

The best cut-off value seemed to be 1274 ng/ml, corresponding to a sensitivity of 100% (95% CI 79.6-100%) and a specificity of 61